Table 3.
Baseline characteristics according to 25 percentile of CTRP3 and CTRP9 levels
| Variables | CTRP3 (ng/ml) | CTRP9 (ng/ml) | ||||
|---|---|---|---|---|---|---|
| ≤136.87 (n = 42) | > 136.87 (n = 126) | P | ≤100.75 (n = 42) | > 100.75 (n = 126) | P | |
| Age (years) | 51.74 ± 19.16 | 59.09 ± 12.80 | 0.019 | 51.48 ± 17.58 | 59.17 ± 13.47 | 0.142 |
| Sex,male (%) | 32(76.2%) | 90(71.4%) | 0.549 | 31(73.8%) | 91(72.2%) | 0.842 |
| BMI (kg/m2) | 22.80 ± 3.86 | 23.66 ± 3.77 | 0.933 | 22.30 ± 3.59 | 23.83 ± 3.80 | 0.462 |
| Diabetes mellitus (%) | 7(16.7%) | 33(26.2%) | 0.209 | 6(14.3%) | 34(27.0%) | 0.094 |
| Hypertension (%) | 10(23.8%) | 56(44.4%) | 0.018 | 7(16.7%) | 59(46.8%) | 0.001 |
| Myocardial infarction (%) | 12(28.6%) | 40(31.7) | 0.700 | 9(21.4%) | 43(34.1%) | 0.123 |
| Disease duration (months) | 44.40 ± 56.92 | 33.21 ± 36.44 | 0.237 | 38.81 ± 42.59 | 35.07 ± 42.70 | 0.574 |
| Systolic pressure (mmHg) | 113.05 ± 22.334 | 121.03 ± 19.83 | 0.287 | 111.71 ± 20.92 | 121.48 ± 20.14 | 0.822 |
| Diastolic pressure (mmHg) | 73.45 ± 14.61 | 76.80 ± 12.09 | 0.443 | 71.43 ± 9.98 | 77.48 ± 13.30 | 0.021 |
| Fasting glucose (mmol/L) | 4.75 ± 1.43 | 5.08 ± 1.83 | 0.275 | 4.45 ± 1.10 | 5.18 ± 1.88 | 0.059 |
| HDL-cholesterol (mmol/L) | 0.86 ± 0.26 | 0.96 ± 0.29 | 0.865 | 0.87 ± 0.30 | 0.95 ± 0.28 | 0.486 |
| LDL-cholesterol (mmol/L) | 2.11 ± 0.84 | 2.40 ± 0.88 | 0.839 | 2.12 ± 0.83 | 2.40 ± 0.89 | 0.731 |
| Total Cholesterol (mmol/L) | 3.45 ± 1.00 | 3.80 ± 0.96 | 0.842 | 3.45 ± 0.98 | 3.80 ± 0.97 | 0.015 |
| Triglyceride (mmol/L) | 1.27 ± 0.71 | 1.42 ± 0.90 | 0.332 | 1.15 ± 0.56 | 1.47 ± 0.92 | 0.873 |
| Serum creatinine (umol/L) | 123.69 ± 36.954 | 110.49 ± 30.89 | 0.214 | 119.33 ± 34.45 | 111.94 ± 32.30 | 0.547 |
| Cystatin c (mg/L) | 1.48 ± 0.43 | 1.35 ± 0.42 | 0.428 | 1.40 ± 0.39 | 1.37 ± 0.44 | 0.828 |
| NT-proBNP<20,000 (ng/L) | 25 (59.5%) | 121(96%) | < 0.001 | 27(64.3%) | 119(94.4%) | < 0.001 |
| LVEF> 25% | 19 (45.2%) | 103(81.7%) | < 0.001 | 21 (50%) | 101 (80.2%) | < 0.001 |